Development and validation of the diabetes fear of injecting and self- testing questionnaire (D-FISQ): First findings

F. J. Snoek, E. D. Mollema, R. J. Heine, L. M. Bouter, H. M. Van Der Ploeg

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

To quantify the degree of fear of self-injecting insulin and self- testing of blood glucose in adult insulin-treated diabetic patients, the Diabetes Fear of Injecting and Self-testing Questionnaire (D-FISQ) was developed. The D-FISQ is a 30-item self-report questionnaire consisting of two subscales that measure Fear of Self-Injecting (FSI) and Fear of Self- Testing (FST). To test validity and internal consistency, the D-FISQ was administered to a sample of 266 insulin-treated patients (Type 1 and Type 2); four diagnosed injection phobic insulin-requiring diabetic patients also completed the D-FISQ. The minimal score was obtained on the subscales by 62% (FSI) and 57% (FST) of the population. The D-FISQ demonstrated high internal consistency, with Cronbach's αs of 0.94 (D-FISQ), 0.94 (FSI), and 0.90 (FST). Spearman rho between fear of self-injecting and fear of self-testing was 0.59 (p < 0.001), justifying two separate subscales. Construct validity was confirmed by a correlation of 0.44 with Spielbergers Trait Anxiety Inventory (Spearman rho, p < 0.001). FSI-scores from the injection phobic patients were all ≤95th percentile, while three scored ≤95% on FST, indicating discriminative validity. Results confirm homogeneity and validity of the D-FISQ and suggest usefulness of this instrument in both clinical practice and research.

LanguageEnglish
Pages871-876
Number of pages6
JournalDiabetic Medicine
Volume14
Issue number10
DOIs
Publication statusPublished - 29 Oct 1997

Cite this

@article{eb20282e0a684fd7880e814f43c5ddcd,
title = "Development and validation of the diabetes fear of injecting and self- testing questionnaire (D-FISQ): First findings",
abstract = "To quantify the degree of fear of self-injecting insulin and self- testing of blood glucose in adult insulin-treated diabetic patients, the Diabetes Fear of Injecting and Self-testing Questionnaire (D-FISQ) was developed. The D-FISQ is a 30-item self-report questionnaire consisting of two subscales that measure Fear of Self-Injecting (FSI) and Fear of Self- Testing (FST). To test validity and internal consistency, the D-FISQ was administered to a sample of 266 insulin-treated patients (Type 1 and Type 2); four diagnosed injection phobic insulin-requiring diabetic patients also completed the D-FISQ. The minimal score was obtained on the subscales by 62{\%} (FSI) and 57{\%} (FST) of the population. The D-FISQ demonstrated high internal consistency, with Cronbach's αs of 0.94 (D-FISQ), 0.94 (FSI), and 0.90 (FST). Spearman rho between fear of self-injecting and fear of self-testing was 0.59 (p < 0.001), justifying two separate subscales. Construct validity was confirmed by a correlation of 0.44 with Spielbergers Trait Anxiety Inventory (Spearman rho, p < 0.001). FSI-scores from the injection phobic patients were all ≤95th percentile, while three scored ≤95{\%} on FST, indicating discriminative validity. Results confirm homogeneity and validity of the D-FISQ and suggest usefulness of this instrument in both clinical practice and research.",
keywords = "Injection phobia, Insulin therapy, Questionnaire Adults, Selfmonitoring of blood glucose, Validation",
author = "Snoek, {F. J.} and Mollema, {E. D.} and Heine, {R. J.} and Bouter, {L. M.} and {Van Der Ploeg}, {H. M.}",
year = "1997",
month = "10",
day = "29",
doi = "10.1002/(SICI)1096-9136(199710)14:10<871::AID-DIA457>3.0.CO;2-Y",
language = "English",
volume = "14",
pages = "871--876",
journal = "Diabetic Medicine",
issn = "0742-3071",
publisher = "Wiley-Blackwell",
number = "10",

}

Development and validation of the diabetes fear of injecting and self- testing questionnaire (D-FISQ) : First findings. / Snoek, F. J.; Mollema, E. D.; Heine, R. J.; Bouter, L. M.; Van Der Ploeg, H. M.

In: Diabetic Medicine, Vol. 14, No. 10, 29.10.1997, p. 871-876.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Development and validation of the diabetes fear of injecting and self- testing questionnaire (D-FISQ)

T2 - Diabetic Medicine

AU - Snoek, F. J.

AU - Mollema, E. D.

AU - Heine, R. J.

AU - Bouter, L. M.

AU - Van Der Ploeg, H. M.

PY - 1997/10/29

Y1 - 1997/10/29

N2 - To quantify the degree of fear of self-injecting insulin and self- testing of blood glucose in adult insulin-treated diabetic patients, the Diabetes Fear of Injecting and Self-testing Questionnaire (D-FISQ) was developed. The D-FISQ is a 30-item self-report questionnaire consisting of two subscales that measure Fear of Self-Injecting (FSI) and Fear of Self- Testing (FST). To test validity and internal consistency, the D-FISQ was administered to a sample of 266 insulin-treated patients (Type 1 and Type 2); four diagnosed injection phobic insulin-requiring diabetic patients also completed the D-FISQ. The minimal score was obtained on the subscales by 62% (FSI) and 57% (FST) of the population. The D-FISQ demonstrated high internal consistency, with Cronbach's αs of 0.94 (D-FISQ), 0.94 (FSI), and 0.90 (FST). Spearman rho between fear of self-injecting and fear of self-testing was 0.59 (p < 0.001), justifying two separate subscales. Construct validity was confirmed by a correlation of 0.44 with Spielbergers Trait Anxiety Inventory (Spearman rho, p < 0.001). FSI-scores from the injection phobic patients were all ≤95th percentile, while three scored ≤95% on FST, indicating discriminative validity. Results confirm homogeneity and validity of the D-FISQ and suggest usefulness of this instrument in both clinical practice and research.

AB - To quantify the degree of fear of self-injecting insulin and self- testing of blood glucose in adult insulin-treated diabetic patients, the Diabetes Fear of Injecting and Self-testing Questionnaire (D-FISQ) was developed. The D-FISQ is a 30-item self-report questionnaire consisting of two subscales that measure Fear of Self-Injecting (FSI) and Fear of Self- Testing (FST). To test validity and internal consistency, the D-FISQ was administered to a sample of 266 insulin-treated patients (Type 1 and Type 2); four diagnosed injection phobic insulin-requiring diabetic patients also completed the D-FISQ. The minimal score was obtained on the subscales by 62% (FSI) and 57% (FST) of the population. The D-FISQ demonstrated high internal consistency, with Cronbach's αs of 0.94 (D-FISQ), 0.94 (FSI), and 0.90 (FST). Spearman rho between fear of self-injecting and fear of self-testing was 0.59 (p < 0.001), justifying two separate subscales. Construct validity was confirmed by a correlation of 0.44 with Spielbergers Trait Anxiety Inventory (Spearman rho, p < 0.001). FSI-scores from the injection phobic patients were all ≤95th percentile, while three scored ≤95% on FST, indicating discriminative validity. Results confirm homogeneity and validity of the D-FISQ and suggest usefulness of this instrument in both clinical practice and research.

KW - Injection phobia

KW - Insulin therapy

KW - Questionnaire Adults

KW - Selfmonitoring of blood glucose

KW - Validation

UR - http://www.scopus.com/inward/record.url?scp=0030769171&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1096-9136(199710)14:10<871::AID-DIA457>3.0.CO;2-Y

DO - 10.1002/(SICI)1096-9136(199710)14:10<871::AID-DIA457>3.0.CO;2-Y

M3 - Article

VL - 14

SP - 871

EP - 876

JO - Diabetic Medicine

JF - Diabetic Medicine

SN - 0742-3071

IS - 10

ER -